• Oteseconazole: From MIC to Assay Meaning

  2026-08-21

  Oteseconazole (VT-1161) is a selective tetrazole CYP51 inhibitor with strong activity against multiple Candida species. This guide goes beyond mechanism to show how exposure, selectivity, resistance phenotype, and assay design should be interpreted together.

• ORAI2 and Early Postirradiation Salivary Fibrosis

  2026-08-20

  The reference study identifies an ORAI2/JNK/NFAT1 signaling axis that connects store-operated calcium entry with TGF-β1-driven fibrosis in irradiated salivary glands. Its combination of transcriptomics, pharmacologic SOCE inhibition, mechanistic signaling analysis, and salivary-function assessment provides a framework for studying early postirradiation tissue remodeling.

• Vardenafil HCl Trihydrate: Proteoform-Aware Assays

  2026-08-20

  Vardenafil HCl Trihydrate supports a layered strategy for PDE5 inhibition assay development, from molecular potency to smooth muscle function. This article shows how native-membrane proteoform analysis can improve interpretation of selectivity, cGMP signaling, and PDE6-related off-target findings.

• E. coli Uracil-DNA Glycosylase (UDG) Guide

  2026-08-19

  E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil from single- and double-stranded DNA and can be incorporated into PCR carryover-contamination control workflows. It is intended for research DNA applications only; it is inactive toward RNA and oligonucleotides shorter than six bases and is not intended for diagnostic or medical use.

• Resiniferatoxin and TRPV1-Positive Afferents

  2026-08-19

  Szallasi’s 2023 review explains how Resiniferatoxin (RTX) converts selective TRPV1 activation into prolonged sensory silencing through desensitization, chemical inactivation, and, under targeted conditions, sensory-neuron ablation. The paper connects molecular pharmacology with preclinical, veterinary, and clinical evidence relevant to osteoarthritis, neuropathic, cancer, postoperative, and bladder pain research.

• Sodium Orthovanadate for Phosphorylation Workflows

  2026-08-18

  Sodium Orthovanadate (Na3VO4) helps preserve labile phosphotyrosine signals during adipocyte lysis, kinase assays, and pathway validation. This guide connects reversible phosphatase inhibition with the PI3K/AKT/GLUT4 workflow used to study insulin resistance, while emphasizing controls, compatibility, and troubleshooting.

• From TBK1 Signaling to Actionable Apoptosis Data

  2026-08-18

  A translational framework for connecting IRG1–itaconate–TBK1 biology with rigorous DNA-fragmentation measurement using Cy5 TUNEL workflows across tissues and cultured cells.

• Azilsartan Medoxomil Monopotassium: Translational Edge

  2026-08-17

  A mechanistic and translational perspective on Azilsartan medoxomil monopotassium (TAK 491), linking durable AT1 receptor antagonism with experimental design, cardiovascular research, and clinically relevant decision-making.

• Oteseconazole: From MIC to Exposure Design

  2026-08-17

  Oteseconazole (VT-1161) is more than a potent Candida CYP51 inhibitor. This guide shows how to translate its selectivity, species profile, and exposure-related properties into more informative antifungal assays and translational decisions.

• Trilaurin: Protocols for Lipid and Enzyme Workflows

  2026-08-16

  Trilaurin, also called Glycerol Tridodecanoate, is a water-insoluble long-chain triacylglycerol used as a lipid excipient, formulation component, and biocatalytic synthesis substrate. This guide addresses solvent selection, short-term stock preparation, particle-formulation workflows, and enzyme-reaction QC while defining why it should not be used as a direct aqueous reagent or stored routinely as a long-term solution.

• EPI-001 AR N-Terminal Domain Inhibitor Workflow

  2026-08-15

  EPI-001 provides a practical way to interrogate androgen receptor transcriptional control beyond the ligand-binding domain, with applications in prostate cancer and exploratory triple-negative breast cancer models. This workflow connects viability, AR expression, migration, and EMT readouts while highlighting solubility, vehicle, and assay-design controls.

• Gastrin I (Human) in Next-Gen GI Translation

  2026-08-14

  Gastrin I (human) offers a controlled way to interrogate CCK2 receptor signaling, proton pump activation, and gastric acid secretion while creating a disciplined bridge to hiPSC-derived intestinal organoids. This thought-leadership article outlines how translational researchers can connect receptor-level biology with gastrointestinal physiology studies, pharmacokinetic modeling, and gastrointestinal disorder research without overstating what current organoid evidence demonstrates.

• Chemerin–cNTS Signaling, Superoxide, and Blood Pressure

  2026-08-14

  The 2024 reference study identifies a chemerin–CMKLR1–NADPH oxidase pathway in the caudal nucleus tractus solitarius that raises sympathetic nerve activity, arterial pressure, and heart rate. Its receptor-dissection experiments further indicate that downstream signaling depends more strongly on PVN NMDA receptors than on AMPA/kainate receptors, refining the interpretation of central glutamatergic control of cardiovascular function.

• Interpreting In Vitro Cancer Drug Responses

  2026-08-13

  Hannah R. Schwartz’s 2022 dissertation distinguishes relative viability from fractional viability, showing that these metrics capture different components of an anticancer response: proliferative arrest and cell death. Its central practical contribution is a framework for interpreting response magnitude together with response timing, improving how in vitro drug studies describe mechanism and treatment effect.

• hiPSC Intestinal Organoids for Pharmacokinetics

  2026-08-13

  Saito and colleagues developed a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be propagated, cryopreserved, and differentiated into intestinal epithelial cells with enterocyte CYP and transporter activities, supporting more human-relevant pharmacokinetic testing than conventional models.

7793 records 3/520 page Previous Next 12345 下5页 Last page